Number of the records: 1  

Compounds for inhibition of fibroblast activation protein

  1. 1.
    SYSNO ASEP0581089
    Document TypeP - Patent
    R&D Document TypePatent or other outcome protected by special legislation
    TitleCompounds for inhibition of fibroblast activation protein
    Author(s) Šimková, Adéla (UOCHB-X) ORCID, RID
    Šácha, Pavel (UOCHB-X) RID, ORCID
    Sidej, Natan (UOCHB-X) ORCID
    Ormsby, Tereza (UOCHB-X) ORCID, RID
    Konvalinka, Jan (UOCHB-X) RID, ORCID
    Year of issue2023
    Possible third party use of the resultA - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence
    Royalty requestedA - Poskytovatel licence požaduje licenční poplatek
    Patent no. or utility model no. or industrial design no.AU2021248368
    Date of the patent acceptance06.04.2023
    Name of the patent ownerÚstav organické chemie a biochemie AV ČR, v. v. i
    Code of the issuer nameAU001 - IP Australia Phillip ACT
    Current useA - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem
    Territorial ProtectionNEU - národní patent v zemi mimo EU
    PCT - mezinárodní patentová ochrana dle Smlouvy o patentové spolupráci
    Languageeng - English
    KeywordsFAP ; protease ; inhibition
    OECD categoryMedicinal chemistry
    R&D ProjectsGA19-10280S GA ČR - Czech Science Foundation (CSF)
    NV15-31379A GA MZd - Ministry of Health (MZ)
    EF16_019/0000729 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2015064 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    NU22-03-00318 GA MZd - Ministry of Health (MZ)
    LX22NPO5102 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUOCHB-X - RVO:61388963
    AnnotationThis invention provides quinolinecarboxamide compounds of general formula I which by far exceed the previously known FAP inhibitors in affinity and inhibitory effect. These agents can be used to specifically target tumours for diagnostic and therapeutic purposes, or for laboratory purposes in the study of endogenous FAP expression.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2024
    Electronic addresshttps://worldwide.espacenet.com/patent/search/family/075953813/publication/AU2021248368B2?q=AU2021248368B2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.